These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34702327)

  • 1. Multi-dimensional fragmentomic assay for ultrasensitive early detection of colorectal advanced adenoma and adenocarcinoma.
    Ma X; Chen Y; Tang W; Bao H; Mo S; Liu R; Wu S; Bao H; Li Y; Zhang L; Wu X; Cai S; Shao Y; Liu F; Peng J
    J Hematol Oncol; 2021 Oct; 14(1):175. PubMed ID: 34702327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection.
    Bao H; Wang Z; Ma X; Guo W; Zhang X; Tang W; Chen X; Wang X; Chen Y; Mo S; Liang N; Ma Q; Wu S; Xu X; Chang S; Wei Y; Zhang X; Bao H; Liu R; Yang S; Jiang Y; Wu X; Li Y; Zhang L; Tan F; Xue Q; Liu F; Cai S; Gao S; Peng J; Zhou J; Shao Y
    Mol Cancer; 2022 Jun; 21(1):129. PubMed ID: 35690859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection and stratification of colorectal cancer using plasma cell-free DNA fragmentomic profiling.
    Zhou J; Pan Y; Wang S; Wang G; Gu C; Zhu J; Tan Z; Wu Q; He W; Lin X; Xu S; Yuan K; Zheng Z; Gong X; JiangHe C; Han Z; Huang B; Ruan R; Feng M; Cui P; Yang H
    Genomics; 2024 Jul; 116(4):110876. PubMed ID: 38849019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer.
    Wang S; Meng F; Li M; Bao H; Chen X; Zhu M; Liu R; Xu X; Yang S; Wu X; Shao Y; Xu L; Yin R
    Am J Respir Crit Care Med; 2023 May; 207(9):1203-1213. PubMed ID: 36346614
    [No Abstract]   [Full Text] [Related]  

  • 5. A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study.
    Chang W; Zhang Z; Jia B; Ding K; Pan Z; Su G; Zhang W; Liu T; Zhong Y; He G; Ren L; Wei Y; Li D; Cui X; Yang J; Shi Y; Bissonnette M; He C; Zhang W; Fan J; Xu J
    Clin Cancer Res; 2024 Aug; 30(15):3337-3348. PubMed ID: 38814264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer.
    Wu X; Zhang Y; Hu T; He X; Zou Y; Deng Q; Ke J; Lian L; He X; Zhao D; Cai X; Chen Z; Wu X; Fan JB; Gao F; Lan P
    Mol Oncol; 2021 Oct; 15(10):2702-2714. PubMed ID: 33694305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
    Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
    Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-Dimensional Fragmentomics Enables Early and Accurate Detection of Colorectal Cancer.
    Cao Y; Wang N; Wu X; Tang W; Bao H; Si C; Shao P; Li D; Zhou X; Zhu D; Yang S; Wang F; Su G; Wang K; Wang Q; Zhang Y; Wang Q; Yu D; Jiang Q; Bao J; Yang L
    Cancer Res; 2024 Jul; ():. PubMed ID: 39073362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study.
    Xiao Q; Lu W; Kong X; Shao YW; Hu Y; Wang A; Bao H; Cao R; Liu K; Wang X; Wu X; Zheng S; Yuan Y; Ding K
    Cancer Lett; 2021 Feb; 499():201-208. PubMed ID: 33249197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
    Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
    Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling.
    Guo W; Chen X; Liu R; Liang N; Ma Q; Bao H; Xu X; Wu X; Yang S; Shao Y; Tan F; Xue Q; Gao S; He J
    EBioMedicine; 2022 Jul; 81():104131. PubMed ID: 35780566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating free DNA in a screening program for early colorectal cancer detection.
    Perrone F; Lampis A; Bertan C; Verderio P; Ciniselli CM; Pizzamiglio S; Frattini M; Nucifora M; Molinari F; Gallino G; Gariboldi M; Meroni E; Leo E; Pierotti MA; Pilotti S
    Tumori; 2014; 100(2):115-21. PubMed ID: 24852853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
    Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review.
    Song D; Wang F; Ju Y; He Q; Sun T; Deng W; Ding R; Zhang C; Xu Q; Qi C; Bao J
    Int J Surg; 2023 Apr; 109(4):925-935. PubMed ID: 36974713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas.
    Gallardo-Gómez M; Rodríguez-Girondo M; Planell N; Moran S; Bujanda L; Etxart A; Castells A; Balaguer F; Jover R; Esteller M; Cubiella J; Gómez-Cabrero D; De Chiara L
    Clin Epigenetics; 2023 Oct; 15(1):157. PubMed ID: 37794510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
    Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
    PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
    Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
    PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma.
    Zheng G; Du L; Yang X; Zhang X; Wang L; Yang Y; Li J; Wang C
    Br J Cancer; 2014 Nov; 111(10):1985-92. PubMed ID: 25233400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.